Description de l'entreprise
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.
Conseil d'administration & Conseil de surveillance
| PDG |
| Stephen S. Schwartz |
| Conseil d'administration |
| Herman Cueto, Jason W. Joseph, John O'Brien, Michael Paulo, Olga Pirogova, Luc Provost, Robin Vacha, David Wang, Rob Woodward, Ginger Zhou |
| Conseil de surveillance |
| Frank E. Casal, Edward P. Bousa, Robyn C. Davis, Didier Hirsch, Martin D. Madaus, Erica J. McLaughlin, Tina S. Nova, Michael Rosenblatt |
Données de l'entreprise
| Nom: |
Azenta Inc |
| Adresse: |
200 Summit Drive 6th Floor,Burlington, Massachusetts 01803 |
| Téléphone: |
+1-978-262-2626 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://www.azenta.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Medical Supplies |
| Fin de l'exercice financier: |
30/09 |
| Flotte libre: |
- |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Sara Silverman |
| Téléphone IR: |
+1-877-373-6374 |
| IR-Fax: |
- |
| E-mail IR: |
ir@azenta.com
|
